Shares of BTG plc (LON:BTG) have received an average rating of “Buy” from the ten analysts that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is GBX 766.44 ($9.98).
BTG has been the subject of a number of recent analyst reports. Shore Capital reiterated a “not rated” rating on shares of BTG plc in a research note on Thursday, July 13th. Numis Securities Ltd reiterated a “buy” rating and issued a GBX 900 ($11.72) target price on shares of BTG plc in a research note on Wednesday, June 14th. Panmure Gordon reiterated a “buy” rating and issued a GBX 737 ($9.60) target price on shares of BTG plc in a research note on Thursday, April 20th. J P Morgan Chase & Co restated a “neutral” rating and set a GBX 750 ($9.77) price objective on shares of BTG plc in a research note on Tuesday, May 23rd. Finally, Jefferies Group LLC restated a “buy” rating and set a GBX 775 ($10.09) price objective on shares of BTG plc in a research note on Tuesday, May 16th.
WARNING: “BTG plc (LON:BTG) Given Average Rating of “Buy” by Brokerages” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.com-unik.info/2017/08/12/btg-plc-lonbtg-receives-gbx-766-44-consensus-pt-from-brokerages-updated-updated-updated.html.
Shares of BTG plc (LON BTG) opened at 641.50 on Friday. The company’s market cap is GBX 2.47 billion. BTG plc has a 1-year low of GBX 528.36 and a 1-year high of GBX 738.50. The company’s 50-day moving average is GBX 670.07 and its 200 day moving average is GBX 630.54.
In related news, insider Rolf Soderstrom sold 22,624 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of GBX 649 ($8.45), for a total transaction of £146,829.76 ($191,209.48).
About BTG plc
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
What are top analysts saying about BTG plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for BTG plc and related companies.